Independent peptide education · Evidence annotated · Research use information
Peptide Library / Epitalon

Epitalon Research Guide

Synthetic tetrapeptide bioregulator

Limited and region-specific
ClassificationSingle Peptide
Evidence tierLimited and region-specific
Research statusEducational reference
01 · At a glance

Overview

Epitalon is included in this independent research library to separate what has been demonstrated from what remains theoretical. The evidence, regulatory status and terminology vary substantially by compound, so claims should be read in the context of the cited literature.

Dosing & reconstitution guide

Epitalon suggested dosing guide

A concise reference to the dosing ranges most often used in approved labeling, clinical research, or published research discussions. Evidence strength is shown so established dosing is not confused with experimental protocol.

Research protocol only
Suggested starting rangeNo approved dose
Typical reference range5–10 mg commonly described
FrequencyOnce daily
TimingConsistent daily timing
Typical durationCommonly described as 10–20 days
RouteSubcutaneous injection

Titration and protocol notes

Published evidence is limited and not sufficient to establish a standard regimen.

Annotated dosage protocol

Each row explains what the dosage represents. Read it with the evidence badge above: labeled doses, clinical-trial doses, and commonly discussed research amounts do not carry equal clinical weight.

PhaseDoseScheduleWhat this dosage means
Lower referenceNo approved doseOnce dailyThe lower end reported in research discussions; it is not a validated human starting prescription.
Commonly cited range5–10 mg commonly describedConsistent daily timingA range repeated in reference protocols. Repetition does not establish safety, efficacy, or an approved regimen.
Duration / reassessmentCommonly described as 10–20 daysReassess before continuingPublished evidence is limited and not sufficient to establish a standard regimen. Dose changes should never be inferred from vial size or convenient syringe units.

Epitalon reconstitution example

This worked example uses a 50 mg vial, 2 mL of diluent, and a 5,000 mcg reference amount.

Vial strength50 mg
Diluent added2 mL
Concentration25 mg/mL
Example draw0.2 mL / 20 units
How this example is calculated: 50 mg ÷ 2 mL = 25 mg/mL. The 5,000 mcg reference amount equals 5 mg. That produces a 0.2 mL draw, or 20 units on a U-100 syringe.

Syringe units assume a U-100 syringe. Always verify the vial label, syringe type, formulation, and arithmetic independently.

Safety, handling, and storage
  • Suggested ranges are educational summaries, not individualized prescriptions.
  • FDA-labeled regimens apply only to the approved product, indication, and delivery system.
  • For experimental compounds, human safety, purity, and effective dosing may be unknown.
  • Follow product-specific sterility, storage, and beyond-use instructions; do not use damaged or contaminated material.
Live concentration math

Epitalon calculator

Enter your laboratory values to calculate concentration, draw volume, syringe units, and portions per vial.

Runs in your browser
Concentration25 mg/mL
Draw volume0.2 mL
On the syringe20 units
Portions per vial10

Deterministic arithmetic for laboratory documentation only. This tool does not select a dose, provide a protocol, or replace qualified medical or laboratory guidance.

02 · How it is studied

Mechanism and research rationale

A short peptide associated with Russian bioregulator research and investigated for pineal, aging and telomerase-related hypotheses.

Aging biology

Pineal research

Cellular senescence

03 · Interpretation

Key facts

  • Evidence tier: Limited and region-specific.
  • Research status and regulatory status are not interchangeable.
  • This page is an educational reference and does not provide personal medical instructions.
04 · Editorial annotations

What to keep in mind

Editorial note: distinguish peer-reviewed findings from supplier or community claims.
Evidence note: study design, species, route and formulation can materially change interpretation.
05 · Sources

References and evidence indexes

  1. PubMed search: Epitalon
  2. ClinicalTrials.gov search
Research notice: This guide is educational and not medical advice. It does not diagnose, treat, prescribe, or recommend personal use.